Neuro Advance
Date: Location: Cost:
October 10, 2018 Harvard Medical School - Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115

Starting at $1950

 

Dress Code:
Business Attire

Register

NEURO ADVANCE BOSTON - 2018 AGENDA

2018 Steering Committee Members:Mark Corrigan, Co-Founder and President of Research and Development, Tremeau Pharmaceuticals; Jonathan LewisExecutive Chairman and Chief Executive Officer, Samus Therapeutics; Murali GopalakrishnanrSenior Director & Head Search & Evaluation Neuroscience, Abbvie; Kiran ReddyCEO, Praxis Precisions Medicines, Inc.; Martin Tolar,CEO, Alzheon

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:45 am

Welcome & Opening Remarks

8:45-9:15 am

Market Outlook 2018: Where are we Now and Where are We Going? 
Klaus D. Mendla
Global Head, Business Development and Licensing CNS, Boehringer Ingelheim International; Erika SmithCEOReNetX Bio 
Moderator: Kiran Reddy, CEOPraxis Precision Medicines 

9:15-9:45 am

The Regulatory Landscape in Neuroscience

9:45-10:15 am

Overcoming Challenges & Clearing Hurdles in Translational Research & Reproducibility
Tom Engber, SVP, Head of Neuropharmacology & Translational ScienceDisarm Therapeutics

10:15-10:45 am

Networking Break

10:45-11:15 am

Emerging Technology Show & Tell 
Ana Maiques, CEONeuroelectrics 

Fireside Chat: Digital Health & Emerging Technology for CNS Indications 
Ana Maiques, CEONeuroelectricsEddie Martucci, Co-Founder & CEOAkili Interactive 
Moderator: Spyros PapapetropoulosEVP, Head of R&D and CMOCavion Pharma 

11:15-12:00 pm

Spotlight Focus: Voyager Therapeutics 
Dinah SahCSOVoyager Therapeutics 

New Paradigms in Treating Neurodegenerative Disorders 
Dinah SahCSOVoyager TherapeuticsMartin TolarFounder, President & CEOAlzheon
Moderator: Jonathan Lewis, Chairman & CEOSamus Therapeuti

12:00-1:00 pm

Networking Lunch

1:00-1:45 pm

Advancements in Neuropsychiatry 

1:45-2:30 pm

Spotlight Focus: WaveLife Sciences 
Paul BolnoPresident & CEOWaveLife Sciences 

Novel Therapeutic Approaches to Neuromuscular Diseases
Paul BolnoPresident & CEOWaveLife Sciences; David GiljohannCEOExicure

2:30-3:00 pm

Networking Break

3:00-3:45 pm

Addressing Neuroinflammation
Alan EzekowitzPresident & CEOAbide Therapeutics; Ole IsacsonProfessor of Neurology/Co-Director of the Neuroregeneration Research InstituteHMS/McLean Hospital

3:45-4:30 pm

Rare Disease Hotspots  

4:30-5:00 pm

Pain & Addiction
Randall Stevens, CMOCentrexion 

5:00-5:30 pm

Riding the Wave of Innovation: What Will Shape the Next 5-10 Years in Neuro? 
Al Robichaud, CSO, Sage Therapeutics 

5:30-5:45 pm

Closing Remarks 

5:45-6:45 pm

Cocktails and Hors d'oeuvres

Supporting Sponsors: (see all sponsors)

<